The 101 references in paper Ia. Proletov Iu., E. Saganova S., A. Smirnov V., Я. Пролетов Ю., Е. Саганова С., А. Смирнов В. (2014) “Биомаркеры в диагностике острого повреждения почек. Сообщение I // Biomarkers In The Diagnosis Of Acute Kidney Injury. Communication I” / spz:neicon:nefr:y:2014:i:4:p:25-35

1
Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem 1991; 37 (5): 695-700
(check this in PDF content)
2
Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am 2005; 89 (3): 457-473
(check this in PDF content)
3
Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004; 15 (7): 1677-1689
(check this in PDF content)
4
Herget Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66 (3): 1115-1122
(check this in PDF content)
5
Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17 (6): 1503-1520
(check this in PDF content)
6
Coca SG, Yalavarthy R, Concato J et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008; 73 (9): 1008-1016
(check this in PDF content)
7
Waikar SS, Bonventre JV. Can we rely on blood urea nitrogen as a biomarker to determine when to initiate dialysis? Clin J Am Soc Nephrol 2006; 1 (5): 903-904
(check this in PDF content)
8
Luke RG. Uremia and the BUN. New Engl J Med 1981; 305 (20): 1213-1215
(check this in PDF content)
9
Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16 (11):3365–3370
(check this in PDF content)
10
Вельков В.В. NGAL – “ренальный тропонин”, ранний маркер острого повреждения почек: актуальность для нефрологии и кардиохирургии. Клинико-лабораторный консилиум 2011; 2 (38): 90-100
(check this in PDF content)
11
Смирнов А.В. Системный подход к анализу кардиоренальных взаимоотношений как первый шаг на пути к нефрологии формата П4. Нефрология 2011; 12 (2): 11-19 Рис. 4. Зависимость суточной экскреции цистатина С с мочой от протеинурии [37].
(check this in PDF content)
12
Mayer P, Mayer B, Mayer G. Systems biology: building a useful model from multiple markers and profiles. Nephrol Dial Transplant 2012; 27(11): 3995-4002
(check this in PDF content)
13
Наточин Ю.В. Нефрология и фундаментальная наука. Нефрология 2012; 16 (1): 9-21
(check this in PDF content)
14
Edelstein CL. Biomarkers in Kidney Disease. Elsevier Inc, 2011
(check this in PDF content)
15
Martensson J, Martling CR, Bel Ml. Novel biomarkers of acute kidney injury and failure: clinical applicability. British Journal of Anaesthesia 2012; 109 (6): 843-850
(check this in PDF content)
16
Awad AS, Rouse M, Huang L, et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 2009; 75 (7): 689-698
(check this in PDF content)
17
Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediat Inflamm. 2009: 137072
(check this in PDF content)
18
Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007; 357 (8): 797-805
(check this in PDF content)
19
Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012; 5 (2): 102-108
(check this in PDF content)
20
Kokkoris S., Pipili C, Grapsa E. Novel Biomarkers of Acute Kidney Injury in the General Adult ICU: A Review. Renal Failure 2013; 35(4):579-591
(check this in PDF content)
21
Tsigou E, Psallida V, Demponeras C. Role of New Biomarkers: Functional and Structural Damage. Crit Care Res Pract. 2013; 2013:361078
(check this in PDF content)
22
Bonventre JV, Vaidya VS, Schmouder R et al. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 2010; 28 (5): 436-440
(check this in PDF content)
23
Tesch GH. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective. Nephrology (Carlton) 2010; 15 (6): 609-616
(check this in PDF content)
24
Noto A, Cibecchini F, Fanos V et al. NGAL and Metabolomics: The Single Biomarker to Reveal the Metabolome Alterations in Kidney Injury. Biomed Res Int. 2013; 612032
(check this in PDF content)
25
Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta. 2000; 1482 (1-2): 272–283
(check this in PDF content)
26
Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase gelatinase associated lipocalin from humans. Genomics. 1997; 45 (1): 17-23
(check this in PDF content)
27
Schmidt Ott KM, Mori K, Li JY, et al. Dual action of neutrophil gelatinase associated lipocalin. J Am Soc Nephrol. 2007; 18 (2): 407-413
(check this in PDF content)
28
Goetz DH, Holmes MA, Borregaard N et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002; 10 (5): 1033–1043
(check this in PDF content)
29
Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002; 10 (5): 1045–1056
(check this in PDF content)
30
Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin–siderophore–iron complex rescues the kidney from ischemia–reperfusion injury. J Clin Invest 2005; 115 (3): 610-621
(check this in PDF content)
31
Devarajan P. Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther 2007; 5 (B): 463-470
(check this in PDF content)
32
Devarajan P. The promise of biomarkers for personalized renal cancer care. Kidney Int 2010; 7(9): 755-757
(check this in PDF content)
33
Supavekin S, Zhang W, Kucherlapati R et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63 (5): 1714–1724
(check this in PDF content)
34
Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker. J Am Soc Nephrol 2003; 14 (10): 2534–2543
(check this in PDF content)
35
Grigoryev DN,Liu M, Hassoun HT et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008; 19 (3): 547–558
(check this in PDF content)
36
Schmidt-Ott KM. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today? Nephrol Dial Transplant 2011; 26 (3): 762-764
(check this in PDF content)
37
Пролетов Я.Ю., Саганова Е.С., Галкина О.В. и др. Роль некоторых биомаркеров в оценке характера почечного повреждения у пациентов с хроническими гломерулопатиями. Нефрология 2013; 17 (1): 60-69
(check this in PDF content)
38
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365 (9466): 1231-1238
(check this in PDF content)
39
Dent C, Dastrala S, Bennet M, et al. Plasma NGAL predicts AKI, morbidity andmortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11 (6): 127-132
(check this in PDF content)
40
Bachorzewska Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophil gelatinase associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006; 26 (3): 287-292
(check this in PDF content)
41
Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105 (3): 485-491
(check this in PDF content)
42
Haase Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery e a prospective cohort study. Crit Care Med 2009; 37 (2): 553-560
(check this in PDF content)
43
Haase-Fielitz A, Bellomo R, Devarajan P. The predictive performance of plasma neutrophil gelatinase associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dialysis Transplant 2009; 24 (11): 3349-3354
(check this in PDF content)
44
Tuladhar SM, Puntmann VO, Soni M, et al. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009; 53 (3):261-266
(check this in PDF content)
45
McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinaseassociated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010; 5 (2): 211-219
(check this in PDF content)
46
Nauta FL, Boertien WE, Bakker SJ, et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 2011; 34 (4): 975–981
(check this in PDF content)
47
Nickolas TL, O’Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148 (11): 810-819
(check this in PDF content)
48
Trachtman H, Christen E, Cnaan A, et al. Urinary neutrophil gelatinase associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol 2006; 21 (7): 989-994
(check this in PDF content)
49
Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelatinase associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multipletrauma patients. Clin Chem Lab Med 2009; 47 (1): 79-82
(check this in PDF content)
50
Wasilewska A., Zoch-Zwierz W., Taranta-Janusz K. et al. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr. Nephrol 2010; 25 (5): 889-897
(check this in PDF content)
51
Martensson J, Bell M, Oldner A et al. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010; 36 (8): 1333–1340
(check this in PDF content)
52
Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelatinase associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008; 36 (4): 1297-1303
(check this in PDF content)
53
Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6 (7): 1639-1645
(check this in PDF content)
54
Hall IE, Yarlagadda SG, Coca SG et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010; 21 (1): 189-197
(check this in PDF content)
55
Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis 2009; 54 (6): 1012-1024
(check this in PDF content)
56
Bolignano D, Coppolino G, Campo S et. al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol. Dial. Transplant 2008; 23 (1): 414-416
(check this in PDF content)
57
Козловская ЛВ, Бобкова ИН, Чеботарева НВ. и др. Нефротический криз неотложное состояние у больных с нефротическим синдромом. Тер арх 2012; 84(6): 68-72
(check this in PDF content)
58
Vanmassenhove J, Vanholder R, Nagler E et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2013; 28(2): 254-273
(check this in PDF content)
59
Михайловская М., Шерстобитов М. Толковый словарь англоязычных терминов медико-биологической статистики. 2009. URL: http:// www.statsoft.ru/coordination/news/news_detail.php?ELEMENT_ID=590
(check this in PDF content)
60
Ichimura T, Asseldonk EJ, Humphreys BD et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008; 118 (5): 1657–1668
(check this in PDF content)
61
Bailly V, Zhang Z, Meier W et al. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002; 277 (42): 39739–39748
(check this in PDF content)
62
Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biobiomarker and much more. Nephrol Dial Transplant. 2009; 24 (11): 3265–3268
(check this in PDF content)
63
Ichimura T, Bonventre JV, Bailly V et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. Journal of Biological Chemistry 1998; 273 (7): 4135–4142
(check this in PDF content)
64
Han WK, Bailly V, Abichandani R et al. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62 (1): 237–244
(check this in PDF content)
65
Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule 1:a tissue and urinary biomarker for nephrotoxicant induced renal injury. Am J Physiol 2004; 286 (3): 552-563
(check this in PDF content)
66
Koyner JL, Vaidya VS, Bennett MR et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010; 5 (12): 2154–2165
(check this in PDF content)
67
Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009; 14 (6): 423–431
(check this in PDF content)
68
Liang XL, Liu SX, Chen YH et al. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospecprospective. Biomarkers. 2010; 15 (4): 332-339
(check this in PDF content)
69
Ek-Von Mentzer BA, Zhang F, Hamilton JA. Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem 2001; 276(19): 15575-15580
(check this in PDF content)
70
Ferguson MA, Vaidya VS, Waikar SS et al. Urinary livertype fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010; 77 (8): 708-714
(check this in PDF content)
71
Negishi K, Noiri E, Doi K et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 2009; 174 (4): 1154-1159
(check this in PDF content)
72
Portilla D, Dent C, Sugaya T, et al. Liver fatty acid binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008; 73 (4): 465-472
(check this in PDF content)
73
Doi K, Noiri E, Sugaya T. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care. Curr Opin Crit Care 2010; 16 (6): 545-549
(check this in PDF content)
74
Nakamura T, Sugaya T, Koide H. Urinary liver type fatty acid binding protein in septic shock: effect of polymyxin B immobilized fiber hemoperfusion. Shock. 2009; 31 (5): 454-459
(check this in PDF content)
75
Matsui K, Kamijo-Ikemori A, Hara M et al. Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clin Exp Nephrol 2011; 15 (2): 220-225
(check this in PDF content)
76
Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103 (1): 11-24
(check this in PDF content)
77
Endre ZH, Pickering JW, Walker RJ et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79 (10): 1119–1130
(check this in PDF content)
78
Siew ED, Ikizler TA, Gebretsadik T et al. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol. 2010; 5 (8): 1497–1505
(check this in PDF content)
79
Bulent Gul CB, Gullulu M, Oral B et al. Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention? Clin Biochem 2008; 41(7-8): 544-547
(check this in PDF content)
80
Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem. 2000; 35: 63–99
(check this in PDF content)
81
Каюков И.Г., Смирнов А.В., Эмануэль В.Л. Цистатин С в современной медицине. Нефрология. 2012; 16 (1): 22-39
(check this in PDF content)
82
Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and exexpression of the human cystatin C gene. Biochem J. 1990; 268 (2): 287-294
(check this in PDF content)
83
Baxmann AC, Ahmed MS, Marques NC et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008; 3 (2): 348–354
(check this in PDF content)
84
Tangri N, Alam A, Giannetti N et al. Predicting glomerular filtration rate in heart transplant recipients using serum creatininebased equations with cimetidine. J Heart Lung Transpl. 2008; 27 (8): 905–909
(check this in PDF content)
85
Herget Rosenthal S, Pietruck F, Volbracht L, et al. Serum cystatin C e a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol. 2005; 64 (1): 41-47
(check this in PDF content)
86
Conti M, Moutereau S, Zater M, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med. 2006; 44 (3): 288–291
(check this in PDF content)
87
Nejat M, Pickering JW, Walker RJ et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010; 25 (10): 3283-3289
(check this in PDF content)
88
Briguori C, Visconti G, Rivera N et al. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010; 121 (19): 2117
(check this in PDF content)
89
Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50 (3): 552–558
(check this in PDF content)
90
Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008; 74 (8): 1059–1069
(check this in PDF content)
91
Nejat M, Pickering JW, Walker RJ, et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care. 2010; 14 (3): R85
(check this in PDF content)
92
Soto K, Coelho S, Rodrigues B, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol. 2010; 5 (10): 1745–1754
(check this in PDF content)
93
Zhang Z, Lu B, Sheng X et. al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis. 2012; 59(4): 590-592
(check this in PDF content)
94
Haase M, Bellomo R, Haase-Fielitz A. Serum cystatin C may diagnose rather than predict acute kidney injury. Am J Kidney Dis 2012; 59(4): 582
(check this in PDF content)
95
Croda-Todd MT, Soto-Montano XJ, Hernández-Cancino PA. Adult cystatin C reference intervals determined by nephelometric immunoassay. Clin Biochem 2007; 40(13-14): 1084-1087
(check this in PDF content)
96
Royakkers AA, Korevaar JC, van Suijlen JD et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 2011; 37(3): 493-501
(check this in PDF content)
97
Spahillari A, Parikh CR, Sint K et al. Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. Am J Kidney Dis 2012; 60(6): 922-929
(check this in PDF content)
98
Fricker M, Wiesli P, Brandle M et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2008; 63 (5): 1944–1947
(check this in PDF content)
99
Risch L, Herklotz R, Blumberg A et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001; 47 (11): 2055–2059
(check this in PDF content)
100
Wegiel B, Jiborn T, Abrahamson M et al. Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. Plos One 2009; 4 (11): 7953
(check this in PDF content)
101
Nejat M, Hill JV, Pickering J et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol. Dial Transplan 2011; 26 (5): 1553-1558 Авторы заявляют об отсутствии конфликта интересов
(check this in PDF content)